B. Jenkins
Immunology · 2018
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Immunology — 27 citations into it; #1,843 of 2,160 by trust here, #2,109 by citations
- Oncology — 25 citations into it; #1,467 of 1,698 by trust here, #1,627 by citations
- Pathology and Forensic Medicine — 12 citations into it
Whom B. Jenkins trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts B. Jenkins overall
Papers from B. Jenkins's perspective
Ordered by how strongly the researchers B. Jenkins trusts endorse each paper. Same corpus, a different order for every researcher.
- STATs in cancer inflammation and immunity: a leading role for STAT3 (Nature Reviews. Cancer)
- Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system (Nature Immunology)
- Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice (Nature Immunology)
- IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.
- gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. (Cancer Cell)
- The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. (Annual Review of Immunology)
- Humanized anti-interleukin-6 receptor antibody
- Principles of interleukin (IL)-6-type cytokine signalling and its regulation. (Biochemical Journal)
- Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells (Science)
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 (Nature Immunology)
Their papers
- Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer (2018) — 942 citations